Natural Product: NPC118189

Natural Product IDNPC118189
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Normelicopicine
IUPAC Name 1-hydroxy-2,3,4-trimethoxy-10-methylacridin-9-one
Synonyms normelicopicine
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL453816
PubChem CID 5378563
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001253] Quinolines and derivatives
        • [CHEMONTID:0001908] Benzoquinolines
          • [CHEMONTID:0000274] Acridines
            • [CHEMONTID:0001811] Acridones

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey UGEKWKMLXLFVIY-UHFFFAOYSA-N
Standard InCHI InChI=1S/C17H17NO5/c1-18-10-8-6-5-7-9(10)13(19)11-12(18)15(21-2)17(23-4)16(22-3)14(11)20/h5-8,20H,1-4H3
SMILES Cn1c2ccccc2c(=O)c2c1c(c(c(c2O)OC)OC)OC

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   315.11 Volume:   313.412
?
Van der Waals volume.
Dense:   1.005 LogP:   2.183
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.188
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.803
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   17.0
TPSA:   69.92
?
Topological Polar Surface Area.
H-Bond Acceptor:   6.0
H-Bond Donor:   1.0 Rings:   3.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.752 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.411 Fsp3:   0.235
MCE-18:   19.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.094 Fluc inhibitor:   0.072
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.483
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.235
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.02 Promiscuous compounds:   0.21

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.079 MDCK Permeability:   -4.748
Pgp-inhibitor:   0.025 Pgp-substrate:   0.207
PAMPA:   0.586
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.002
20% Bioavailability (F20%):   0.007 30% Bioavailability (F30%):   0.008
50% Bioavailability (F50%):   0.309

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.875 MRP1:   0.998
Plasma Protein Binding (PPB):   96.756% Volume Distribution (VD):   -0.261
Fu: 2.758%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.407
OATP1B3 inhibitor:   0.913 BCRP inhibitor:   0.018
BSEP inhibitor:   0.457

ADMET: Metabolism

CYP1A2-inhibitor:   0.923 CYP1A2-substrate:   0.018
CYP2C19-inhibitor:   0.033 CYP2C19-substrate:   0.049
CYP2C9-inhibitor:   0.009 CYP2C9-substrate:   0.001
CYP2D6-inhibitor:   0.003 CYP2D6-substrate:   0.002
CYP3A4-inhibitor:   0.947 CYP3A4-substrate:   0.413
CYP2B6-substrate:   0.001 CYP2C8-inhibitor:   0.031
HLM stability:   0.961
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.48 Half-life (T1/2):  1.397

ADMET: Toxicity

hERG Blockers:  0.171 hERG Blockers (10um):  0.6
Human Hepatotoxicity (H-HT):  0.657 Drug-induced Liver Injury (DILI):  0.647
AMES Toxicity:  0.59 Rat Oral Acute Toxicity:  0.395
Maximum Recommended Daily Dose:  0.369 Skin Sensitization:  0.752
Carcinogencity:  0.76 Eye Corrosion:  0.024
Eye Irritation:  0.712 Respiratory Toxicity:  0.787
Drug-induced Neurotoxicity:  0.848 Ototoxicity:  0.426
Hematotoxicity:  0.633 Drug-induced Nephrotoxicity:  0.474
Genotoxicity:  0.22 RPMI-8226 Immunitoxicity:  0.141
A549 Cytotoxicity:  0.271 Hek293 Cytotoxicity:  0.407
BCF:   1.472
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.731
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.888
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.182
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6049 Teclea trichocarpa Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[12141852]
NPO6049 Teclea trichocarpa Species Rutaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO3659 Limonium bicolor Species Plumbaginaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO1947 Nemopilema nomurai Species Rhizostomatidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3659 Limonium bicolor Species Plumbaginaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO6049 Teclea trichocarpa Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell line KB Homo sapiens IC50 > 328000.0 nM PMID[12141852]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 8250.0 nM PMID[12141852]
NPT474 Organism Plasmodium berghei Plasmodium berghei Activity = 32.1 % PMID[12141852]
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 IC50 = 14700.0 nM PMID[12141852]
NPT2 Others Unspecified n.a. Ratio IC50 = 22.0 n.a. PMID[12141852]
NPT2 Others Unspecified n.a. Ratio IC50 = 40.0 n.a. PMID[12141852]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC118189 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7059 Intermediate Similarity NPC220241
0.6792 Remote Similarity NPC76478
0.66 Remote Similarity NPC268223
0.6111 Remote Similarity NPC206109
0.5926 Remote Similarity NPC134702
0.5893 Remote Similarity NPC157983
0.5741 Remote Similarity NPC295479
0.5556 Remote Similarity NPC298320
0.5517 Remote Similarity NPC118154
0.5357 Remote Similarity NPC114039
0.5106 Remote Similarity NPC45389
0.5094 Remote Similarity NPC112937
0.5085 Remote Similarity NPC182853

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC118189 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6296 Remote Similarity NPD2899 Discontinued

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data